1. Home
  2. RDY vs RTO Comparison

RDY vs RTO Comparison

Compare RDY & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • RTO
  • Stock Information
  • Founded
  • RDY 1984
  • RTO 1925
  • Country
  • RDY India
  • RTO United Kingdom
  • Employees
  • RDY N/A
  • RTO N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • RTO Business Services
  • Sector
  • RDY Health Care
  • RTO Consumer Discretionary
  • Exchange
  • RDY Nasdaq
  • RTO Nasdaq
  • Market Cap
  • RDY 13.1B
  • RTO 13.1B
  • IPO Year
  • RDY N/A
  • RTO N/A
  • Fundamental
  • Price
  • RDY $13.99
  • RTO $25.65
  • Analyst Decision
  • RDY Buy
  • RTO Hold
  • Analyst Count
  • RDY 1
  • RTO 2
  • Target Price
  • RDY $17.00
  • RTO $29.00
  • AVG Volume (30 Days)
  • RDY 770.6K
  • RTO 696.6K
  • Earning Date
  • RDY 11-05-2024
  • RTO 11-26-2024
  • Dividend Yield
  • RDY 4.04%
  • RTO 2.27%
  • EPS Growth
  • RDY 4.63
  • RTO 24.34
  • EPS
  • RDY 0.76
  • RTO 0.20
  • Revenue
  • RDY $3,579,112,656.00
  • RTO $6,837,109,965.00
  • Revenue This Year
  • RDY $13.39
  • RTO $3.98
  • Revenue Next Year
  • RDY $8.35
  • RTO $2.50
  • P/E Ratio
  • RDY $18.83
  • RTO $25.58
  • Revenue Growth
  • RDY 12.37
  • RTO 12.40
  • 52 Week Low
  • RDY $12.90
  • RTO $22.40
  • 52 Week High
  • RDY $16.89
  • RTO $34.07
  • Technical
  • Relative Strength Index (RSI)
  • RDY 32.92
  • RTO 48.19
  • Support Level
  • RDY $13.97
  • RTO $25.42
  • Resistance Level
  • RDY $14.40
  • RTO $26.07
  • Average True Range (ATR)
  • RDY 0.27
  • RTO 0.40
  • MACD
  • RDY -0.04
  • RTO -0.05
  • Stochastic Oscillator
  • RDY 9.72
  • RTO 7.83

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.

Share on Social Networks: